Division of Cardiovascular Diseases, Department of Internal Medicine, Wayne State University, Detroit, Michigan.
University Hospitals, Case Western Reserve University, Cleveland, Ohio.
JAMA Netw Open. 2024 Apr 1;7(4):e245292. doi: 10.1001/jamanetworkopen.2024.5292.
Reducing exposure to fine particulate matter (<2.5 μm [PM2.5]) air pollution improves cardiopulmonary morbidity and mortality. However, the public health relevance of air quality index (AQI) activity guidelines under present-day environmental conditions in the US has not been critically assessed.
To evaluate the public health relevance of following PM2.5 AQI activity guidance in preventing serious atherosclerotic cardiovascular disease (ASCVD) and pulmonary events among adults in the US.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional modeling study involved the general adult population and sensitive individuals as designated by the US Environmental Protection Agency (EPA), including adults with preexisting ASCVD or lung disease (asthma or chronic obstructive pulmonary disease). The study was conducted between August 1, 2023, and January 31, 2024.
Daily AQI strata for PM2.5 and the corresponding activity recommendations.
The main outcome was the number needed to treat (NNT) per day by following activity guidance across daily AQI strata to prevent 1 serious ASCVD or pulmonary event among relevant populations. To calculate PM2.5-induced excess disease event rates per day, estimated baseline disease-specific daily event rates for each group were multiplied by the increase in risks due to PM2.5 levels at each AQI stratum. The number of events prevented per day was calculated by multiplying each excess disease event rate by the percentage in exposure reduction plausibly incurred by following population-specific activity guidance at each AQI level. The NNT is the reciprocal of the number of events prevented.
The NNT to prevent ASCVD events was high for the general population and for patients with ASCVD across all AQI strata. The range of values was comparatively lower to prevent pulmonary events among adults with lung disease. During most days (96%) when activity recommendations were promulgated due to elevated PM2.5 (AQI, 101-200), the NNT to prevent a serious disease event remained very high for the general population (>18 million), patients with ASCVD (approximately 1.6-5 million), and adults with lung disease (approximately 66 000-202 000).
These findings suggest that existing PM2.5 AQI activity recommendations are of questionable public health relevance in present-day conditions and merit consideration for updating to improve their potential effectiveness.
减少细颗粒物(<2.5μm [PM2.5])空气污染暴露可改善心肺发病率和死亡率。然而,目前在美国的环境条件下,空气质量指数(AQI)活动指南对公众健康的相关性尚未得到严格评估。
评估美国成年人遵循 PM2.5 AQI 活动指南预防严重动脉粥样硬化性心血管疾病(ASCVD)和肺部事件的公共卫生相关性。
设计、地点和参与者:这是一项横断面建模研究,涉及普通成年人群体和美国环境保护署(EPA)指定的敏感个体,包括患有既往 ASCVD 或肺部疾病(哮喘或慢性阻塞性肺疾病)的成年人。研究于 2023 年 8 月 1 日至 2024 年 1 月 31 日进行。
PM2.5 的每日 AQI 分层和相应的活动建议。
主要结果是在相关人群中,遵循每日 AQI 分层的活动建议以预防 1 例严重 ASCVD 或肺部事件的每日治疗人数(NNT)。为了计算 PM2.5 引起的每日超额疾病事件发生率,为每组估计了基线疾病特异性每日事件发生率,乘以每个 AQI 分层中 PM2.5 水平引起的风险增加。通过将每个超额疾病事件率乘以每个 AQI 水平下特定人群活动指南的暴露减少比例来计算每日预防的事件数。NNT 是预防事件数的倒数。
对于普通人群和患有 ASCVD 的患者,在所有 AQI 分层中,预防 ASCVD 事件的 NNT 都很高。对于患有肺部疾病的成年人,预防肺部事件的数值范围相对较低。在由于 PM2.5 升高(AQI,101-200)而发布活动建议的大多数日子(96%)中,普通人群(>1800 万)、患有 ASCVD 的患者(约 160 万至 500 万)和患有肺部疾病的成年人(约 66000 至 202000)预防严重疾病事件的 NNT 仍然非常高。
这些发现表明,现有的 PM2.5 AQI 活动建议在当前条件下对公众健康的相关性值得怀疑,需要考虑更新以提高其潜在效果。